Wwwint.iconplc.com
How Patients and Developers Benefit in a Digital Health Ecosystem
WEBEmerging mHealth technologies are transforming patient care by integrating health data across the healthcare landscape. Wearable mobile sensors, smart drug delivery devices, smartphone apps and individualised telemedicine increasingly provide continuous data collection, treatment adjustment and active patient engagement in real time.
Actived: 9 days ago
URL: https://wwwint.iconplc.com/insights/blog/2018/04/18/benefits-to-digital-health-ecosystem/
Infectious diseases and vaccines thought leadership ICON plc
WEBPandemic respiratory vaccine clinical trials: A departure from business as usual. Vaccine trials for respiratory viruses, even in the best of circumstances, present a number of operational challenges for researchers, many of which are exacerbated in the face of a pandemic created by a novel virus.
ICON and PRA Health Sciences Press Release ICON plc
WEBDublin, Ireland, 24th February 2021-ICON plc, (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations, today announced it has entered into a definitive agreement to …
ICON Digital Platform ICON plc
WEBThe ICON Digital Platform is an end-to-end solution to enable patient services throughout the clinical trial. Its ease of use supports patient centricity and reduces the barriers to trial participation thus enhancing equity, diversity and inclusion.. It has the technical functionality, standard capability, integrated services and the flexibility for any study design or …
How Value-Based Healthcare Affects Medical Device Development
WEBRead this MPO Magazine article written by ICON expert Vicki Anastasi on how value-based healthcare (VBHC) models are expected to transform the health sector, impacting every aspect from patient care to drug pricing, and how partnering with a CRO can help manufacturers to demonstrate clinical efficacy and cost impact of new devices.
World's First Global Patient Outcomes Benchmarking Platform
WEBDublin, Ireland, 27 October 2017 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and the International Consortium for Health Outcomes Measurement (ICHOM), a non-profit organization with the mission of driving value based health care, …
Disease surveillance in low- and middle-income countries
WEBDisease surveillance and reporting is critical to public health, enabling faster and better response to infectious disease outbreaks. As outlined in a previous blog, disease surveillance also plays an important role in developing vaccines for emerging infectious diseases more quickly, which, in turn, helps to limit the spread of these diseases.
World-leading healthcare intelligence and clinical research
WEBThe combined company will leverage its enhanced operations to transform clinical trials and accelerate biopharma customer’s commercial success through the development of medicines and medical devices.
ICON Acquires Mapi Group
WEBICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired the Mapi Group, a leading Patient-Centred Health Outcomes Research and Commercialisation company. The acquisition strengthens …
ICON releases latest version of its Digital Platform
WEBDublin, Ireland – 26 June 2023 – ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced the latest release of its Digital Platform.The platform supports seamless integration of ICON patient, site and sponsor services with the delivery of harmonised data and can be customised for any …
Acquisition of MolecularMD Laboratories ICON plc
WEBAcquisition enhances ICON’s laboratory offering in molecular diagnostic testing and immunohistochemistry Dublin, Ireland, 21 February, 2019 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it …
Top Categories
Popular Searched
› Healthy creamy mushroom pasta
› Total health care ltd peterborough
› Find a 24 hour health care provider
› Last mile health malawi jobs
› Healthcare benefits for veterans
› The core public health function assessment means
› Unitedhealthcare phone number please
› Minnesota home health license verification
Recently Searched
› La paloma health care oceanside ca
› Confluence health uniform requirements
› Florida department of health reviews
› Starting a home healthcare business
› Universalist mental health network
› Social determinants of health billing
› National health bill nigeria
› Metro health locations near me